GLURENORM 30mg tablets medication leaflet

A10BB08 gliquidone • Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas

Gliquidonum is an antidiabetic medication from the sulfonylurea class, used for the treatment of type 2 diabetes mellitus. It stimulates insulin secretion from the pancreas, helping to lower blood glucose levels.

The medication is administered orally, usually before meals, and is particularly indicated for patients with reduced renal function due to its predominantly hepatic elimination.

Common side effects include hypoglycemia, nausea, and weight gain. It is important for patients to adhere to their diet and monitor blood glucose levels to prevent complications.

Gliquidonum is an effective option for managing type 2 diabetes, helping to maintain adequate glycemic control.

General data about GLURENORM 30mg

Substance: gliquidone

Date of last drug list: 01-06-2025

Commercial code: W03352001

Concentration: 30mg

Pharmaceutical form: tablets

Quantity: 60

Product type: original

Price: 57.95 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: BOEHRINGER INGELHEIM ELLAS A.E. - GRECIA

Holder: BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA

Number: 9794/2017/01

Shelf life: 5 years

Compensation lists for GLURENORM 30mg BOEHRINGER

NHP 5 (C2) - Diabetes

Price

Copayment

Patient

57.95 RON

57.95 RON

0.00 RON